文献速递神经儿科影像MR

儿童髓鞘少突胶质细胞糖蛋白抗体相关疾病(MOGAD)的临床与影像表现:从初诊到复发

Clinical and Imaging Findings in Children with Myelin Oligodendrocyte Glycoprotein Antibody Associated Disease (MOGAD): From Presentation to Relapse.
PubMed 文献 · AJNR Am J Neuroradiol · 2024-02-07

回顾性纳入1997至2020年61例血清抗体阳性儿童MOGAD,分析初诊及复发时脑、眶、脊髓MRI表现。初诊脑受累78.6%(44/56)、视路55.4%(31/56)、脊髓19.6%(11/56);影像模式随年龄变化,≤9岁更常见ADEM样模式,>9岁更常见视神经炎及FLAIR高信号伴癫痫的脑炎模式;初诊年龄较小与复发时间较长相关。

要点

  • 儿童MOGAD初诊脑受累78.6%,以额叶及皮层下白质常见,丘脑和脑桥各占47.7%。
  • 视神经炎多双侧(80.6%),常累及眶内段(77.4%);脊髓病灶多位于颈髓且多灶(各72.7%)。
  • 影像模式呈年龄依赖:≤9岁更常见ADEM样模式,>9岁更常见视神经炎及FLAIR高信号伴癫痫的脑炎模式。

核心结论

  • 儿童MOGAD的CNS影像表现随年龄变化,初诊及首次复发时影像模式呈年龄依赖性;初诊年龄较小与复发时间较长相关。

研究设计与样本

  • 回顾性研究,纳入1997至2020年在本机构评估的61例血清抗体阳性MOGAD儿童(女34例),初诊平均年龄7岁(IQR 4-11),复习初诊及复发时脑、眶、脊髓MRI。

关键影像表现/征象

  • 初诊脑受累78.6%(44/56),常见于额叶(70.5%,31/44)和皮层下白质(75%,33/44),丘脑和脑桥各47.7%(21/44)。
  • 初诊视路受累55.4%(31/56),视神经炎多双侧(80.6%,25/31),常累及眶内段(77.4%,24/31)。
  • 初诊脊髓受累19.6%(11/56),病灶多位于颈髓(72.7%,8/11)且多灶(72.7%,8/11)。
  • ≤9岁儿童初诊ADEM样影像模式占39.4%(13/33),首次复发占34.8%(8/23);>9岁儿童初诊视神经炎占34.8%(8/23,P = .001),首次复发FLAIR高信号伴癫痫的脑炎模式占27.8%(5/18,P = .008)。

诊断标准与关键数值

  • 血清抗体阳性为MOGAD入组标准。
  • 影像模式按年龄分组比较:≤9岁与>9岁,初诊ADEM样模式39.4%(13/33)vs 首次复发34.8%(8/23)。
  • >9岁初诊视神经炎34.8%(8/23,P = .001),首次复发FLAIR高信号伴癫痫的脑炎模式27.8%(5/18,P = .008)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Myelin oligodendrocyte glycoprotein-antibody associated disease (MOGAD) is an increasingly recognized cause of demyelinating disease in children. The purpose of this study is to characterize the CNS imaging manifestations of pediatric MOGAD and identify clinical and imaging variables associated with relapse.

MATERIALS AND METHODS: We retrospectively identified children with serum antibody-positive MOGAD evaluated at our institution between 1997 and 2020. Clinical and demographic data were collected. MRIs of the brain, orbit, and spine at presentation and relapse were reviewed for location and pattern of abnormality.

RESULTS: Among 61 cases (34 girls), mean age at presentation was 7 years (IQR 4-11). At presentation, there was imaging involvement of the brain in 78.6% (44/56), optic pathway in 55.4% (31/56), and spine in 19.6% (11/56). Brain involvement was commonly in the frontal (70.5%, 31/44) and subcortical (75%, 33/44) white matter, with involvement of the thalamus and pons in 47.7% each (21/44). Optic neuritis (ON) was commonly bilateral (80.6%, 25/31) involving intraorbital segments (77.4%, 24/31). Spinal cord lesions were typically cervical (72.7%, 8/11) and multifocal (72.7%, 8/11).The imaging patterns were age-dependent; children ≤9 years more commonly demonstrated ADEM-like imaging pattern at presentation (39.4%, 13/33) and first relapse (8/23, 34.8%), while children >9 years more commonly had ON at presentation (34.8%, 8/23, P = .001) and FLAIR-hyperintense lesions in anti-MOG-associated encephalitis with seizures at first relapse (5/18, 27.8%, P = .008).

CONCLUSIONS: We describe the CNS imaging findings in pediatric MOGAD. The imaging pattern is age-dependent at presentation and first relapse. Younger age at presentation is associated with longer time to relapse.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. George E, Russ JB, Validrighi A, et al. Clinical and Imaging Findings in Children with Myelin Oligodendrocyte Glycoprotein Antibody Associated Disease (MOGAD): From Presentation to Relapse. AJNR Am J Neuroradiol. 2024. PMID: 38176731. doi:10.3174/ajnr.A8089

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。